Work

Randomized phase II trial of single agent erlotinib vs. standard chemotherapy in patients with advanced non-small cell lung cancer (NSCLC) and performance status (PS) of 2

Year: 2006

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2006.24.18_suppl.7022

Authors: R. Lilenbaum, R. Axerold, S. Thomas, A. Dowlati, L. Seigel, D. Albert, C. Van Duym, D. Bodkin

Institutions: Thomas Jefferson University, Holy Cross Hospital, Mount Sinai Medical Center, Case Western Reserve University

Language: English

Topic: Lung Cancer Treatments and Mutations

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2260051639

Cites:

Cited by: 24

Related to: 10